feed,title,long_url,short_url
Benzinga,Antares Pharma's Oral Testosterone Treatment Scores FDA Approval,https://benzinga.com/general/biotech/22/03/26352316/antares-pharmas-oral-testosterone-treatment-scores-fda-approval,https://bit.ly/3J2axV7
Benzinga,Ark Fund Buys First Shares Of This Metaverse Related Company; Cathie Wood Says 'We're Going To Have Our Digital Twins',https://benzinga.com/news/22/03/26350876/ark-fund-buys-first-shares-of-this-metaverse-related-company-cathie-wood-says-were-going-to-have-our,https://bit.ly/3iKXTPr
Benzinga,Ocuphire Pharma's Shares Fall Despite Positive Data From Registrational Phase 3 Trial Of Nyxol,https://benzinga.com/general/biotech/22/03/26351237/ocuphire-pharmas-shares-fall-despite-positive-data-from-registrational-phase-3-trial-of-nyxol,https://bit.ly/3wKyWf4
